Variant report
Variant | nsv603039 |
---|---|
Chromosome Location | chr6:48928544-48942969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:48923639..48925740-chr6:48930258..48932509,2 | K562 | blood: | |
2 | chr6:48925640..48928560-chr6:48933916..48936835,2 | K562 | blood: | |
3 | chr6:48930520..48932119-chr6:48937053..48938837,2 | MCF-7 | breast: | |
4 | chr6:48930520..48932119-chr6:48937053..48938837,2 | MCF-7 | breast: | |
5 | chr6:48925640..48928560-chr6:48933916..48936835,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16878481 | chr6:48928544-48928545 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs542147562 | chr6:48928546-48928547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560371772 | chr6:48928547-48928548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112613267 | chr6:48928593-48928594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111704914 | chr6:48928625-48928626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202139391 | chr6:48928633-48928634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74422001 | chr6:48928659-48928660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76007361 | chr6:48928660-48928661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544849393 | chr6:48928676-48928677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187554424 | chr6:48928682-48928683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147532324 | chr6:48928683-48928684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372151358 | chr6:48928687-48928688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550581931 | chr6:48928712-48928713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549996361 | chr6:48928732-48928733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375436978 | chr6:48928748-48928749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12209867 | chr6:48928771-48928772 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs192599356 | chr6:48928777-48928778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112748638 | chr6:48928783-48928784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111552928 | chr6:48928786-48928787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531192663 | chr6:48928814-48928815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566856195 | chr6:48928853-48928854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184800022 | chr6:48928929-48928930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539457143 | chr6:48929020-48929021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557773547 | chr6:48929085-48929086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569763272 | chr6:48929092-48929093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536741973 | chr6:48929114-48929115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545411302 | chr6:48929122-48929123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574941464 | chr6:48929147-48929148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188110468 | chr6:48929152-48929153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192683677 | chr6:48929168-48929169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72863632 | chr6:48929186-48929187 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs375254545 | chr6:48929201-48929202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34007350 | chr6:48929230-48929231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183791416 | chr6:48929304-48929305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373336482 | chr6:48929347-48929348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6906485 | chr6:48929363-48929364 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs75920866 | chr6:48929385-48929386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531873836 | chr6:48929392-48929393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543561980 | chr6:48929402-48929403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs36068984 | chr6:48929442-48929443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189143657 | chr6:48929457-48929458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529303815 | chr6:48929491-48929492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529100862 | chr6:48929546-48929547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547583218 | chr6:48929590-48929591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566016177 | chr6:48929608-48929609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533245366 | chr6:48929621-48929622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551440879 | chr6:48929636-48929637 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192536688 | chr6:48929657-48929658 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184221705 | chr6:48929694-48929695 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369229500 | chr6:48929743-48929744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:48832200-48944000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr6:48928800-48930000 | Enhancers | Hela-S3 | cervix |
3 | chr6:48929400-48930800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:48929600-48930000 | Enhancers | Fetal Lung | lung |
5 | chr6:48933000-48933600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr6:48933400-48934000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |